Topical tacrolimus may enhance repigmentation with targeted narrowband ultraviolet B to treat vitiligo: a randomized, controlled study.
Klahan
S
S
Asawanonda
P
P
D000287:Administration, Topical; D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy / Q000379:methods; D003879:Dermatologic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016037:Single-Blind Method; D012880:Skin Pigmentation / Q000187:drug effects / Q000528:radiation effects; D016559:Tacrolimus / Q000008:administration & dosage*; D014467:Ultraviolet Therapy / Q000379:methods*; D014820:Vitiligo / Q000188:drug therapy* / Q000532:radiotherapy*
D003879:Dermatologic Agents; D016559:Tacrolimus